REFERENCES
[1] S.S. Virani, A. Alonso, E.J. Benjamin, et al,
Heart Disease and Stroke Statistics—2020 Update: A Report From the
American Heart Association, Circulation. 141 (2020).
https://doi.org/10.1161/CIR.0000000000000757.
[2] D.S. Wald, J.K. Morris, N.J. Wald, et al,
Randomized Trial of Preventive Angioplasty in Myocardial Infarction, N.
Engl. J. Med. 369 (2013) 1115–1123.
https://doi.org/10.1056/NEJMoa1305520.
[3] H. Xu, X. Zhang, J. Li, et al, Complete versus
culprit-only revascularization in patients with ST-segment elevation
myocardial infarction and multivessel disease: a meta-analysis of
randomized trials, BMC Cardiovasc. Disord. 19 (2019) 91.
https://doi.org/10.1186/s12872-019-1073-8.
[4] C. Wu, A.-M. Dyer, S.B. King, et al, Impact of
Incomplete Revascularization on Long-Term Mortality After Coronary
Stenting, Circ. Cardiovasc. Interv. 4 (2011) 413–421.
https://doi.org/10.1161/CIRCINTERVENTIONS.111.963058.
[5] Z. Gao, B. Xu, Y. Yang, et al, Long-term
outcomes of complete versus incomplete revascularization after
drug-eluting stent implantation in patients with multivessel coronary
disease, Catheter. Cardiovasc. Interv. 82 (2013) 343–349.
https://doi.org/10.1002/ccd.24799.
[6] B.R. Chaitman, A.D. Rosen, D.O. Williams, et
al, Myocardial Infarction and Cardiac Mortality in the Bypass
Angioplasty Revascularization Investigation (BARI) Randomized Trial,
Circulation. 96 (1997) 2162–2170.
https://doi.org/10.1161/01.CIR.96.7.2162.
[7] P.W. Serruys, M.-C. Morice, A.P. Kappetein, et
al, Percutaneous Coronary Intervention versus Coronary-Artery Bypass
Grafting for Severe Coronary Artery Disease, N. Engl. J. Med. 360 (2009)
961–972. https://doi.org/10.1056/NEJMoa0804626.
[8] M.E. Farkouh, M. Domanski, L.A. Sleeper, et
al, Strategies for Multivessel Revascularization in Patients with
Diabetes, N. Engl. J. Med. 367 (2012) 2375–2384.
https://doi.org/10.1056/NEJMoa1211585.
[9] E.J. Velazquez, K.L. Lee, R.H. Jones, et al,
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy,
N. Engl. J. Med. 374 (2016) 1511–1520.
https://doi.org/10.1056/NEJMoa1602001.
[10] M.R. Patel, J.H. Calhoon, G.J. Dehmer, et al,
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for
Coronary Revascularization in Patients With Stable Ischemic Heart
Disease, J. Am. Coll. Cardiol. 69 (2017) 2212–2241.
https://doi.org/10.1016/j.jacc.2017.02.001.
[11] C. Spadaccio, U. Benedetto, Coronary artery
bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in
the treatment of multivessel coronary disease: quo vadis? —a review of
the evidences on coronary artery disease, Ann. Cardiothorac. Surg. 7
(2018) 506–515. https://doi.org/10.21037/acs.2018.05.17.
[12] P.T. O’Gara, F.G. Kushner, D.D. Ascheim, et
al, 2013 ACCF/AHA Guideline for the Management of ST-Elevation
Myocardial Infarction, Circulation. 127 (2013).
https://doi.org/10.1161/CIR.0b013e3182742cf6.
[13] L. Lambert, Association Between Timeliness of
Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial
Infarction, JAMA. 303 (2010) 2148.
https://doi.org/10.1001/jama.2010.712.
[14] B.R. Brodie, T.D. Stuckey, T.C. Wall, et al,
Importance of time to reperfusion for 30-day and late survival and
recovery of left ventricular function after primary angioplasty for
acute myocardial infarction, J. Am. Coll. Cardiol. 32 (1998) 1312–1319.
https://doi.org/10.1016/S0735-1097(98)00395-7.
[15] C.P. Cannon, Relationship of
Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in
Patients Undergoing Angioplasty for Acute Myocardial Infarction, JAMA.
283 (2000) 2941. https://doi.org/10.1001/jama.283.22.2941.
[16] 2014 Introduction to the NRD. Healthcare Cost
and Utilization Project (HCUP), Agency Healthc. Res. Qual. Rockv. M.
(n.d.). www. hcup-us. ahrq. gov/db/nation/nrd/NRD_Introduction_2014.
jsp.
[17] K.L.C. Gibson T, Casto A, Young J, Impact of
ICD-10- CM/PCS on Research Using Administrative Databases, . . HCUP
Methods Ser. Rep. # 2016- 02 ONLINE. July 25, 2016. U.S. Agency
Healthc. Res. Qual. (n.d.). available:
http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp.
[18] R. Khera, S. Angraal, T. Couch, et al,
Adherence to Methodological Standards in Research Using the National
Inpatient Sample, JAMA. 318 (2017) 2011.
https://doi.org/10.1001/jama.2017.17653.
[19] M.A. Pourhoseingholi, A.R. Baghestani, M.
Vahedi, How to control confounding effects by statistical analysis.,
Gastroenterol. Hepatol. from Bed to Bench. 5 (2012) 79–83.
http://www.ncbi.nlm.nih.gov/pubmed/24834204.
[20] M.S.H.P. 2014. McDonald JH. Handbook of
Biological Statistics. 3rd ed. Baltimore, No Title, (n.d.).
[21] T. Doenst, A. Haverich, P. Serruys, et al,
PCI and CABG for Treating Stable Coronary Artery Disease, J. Am. Coll.
Cardiol. 73 (2019) 964–976. https://doi.org/10.1016/j.jacc.2018.11.053.
[22] S.-J. Park, J.-M. Ahn, Y.-H. Kim, et al, BEST
Trial Investigators, Trial of everolimus-eluting stents or bypass
surgery for coronary disease., N. Engl. J. Med. 372 (2015) 1204–12.
https://doi.org/10.1056/NEJMoa1415447.
[23] M. Chang, C.W. Lee, J.-M. Ahn, et al,
Comparison of Outcome of Coronary Artery Bypass Grafting Versus
Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary
Syndrome., Am. J. Cardiol. 120 (2017) 380–386.
https://doi.org/10.1016/j.amjcard.2017.04.038.
[24] P. Freitas, M. Madeira, L. Raposo, et al,
Coronary Artery Bypass Grafting Versus Percutaneous Coronary
Intervention in Patients With Non-ST-Elevation Myocardial Infarction and
Left Main or Multivessel Coronary Disease., Am. J. Cardiol. 123 (2019)
717–724. https://doi.org/10.1016/j.amjcard.2018.11.052.
[25] S.J. Head, M. Milojevic, D.P. Taggart, et al,
Current Practice of State-of-the-Art Surgical Coronary
Revascularization, Circulation. 136 (2017) 1331–1345.
https://doi.org/10.1161/CIRCULATIONAHA.116.022572.
[26] S.J. Head, S. Kaul, M.J. Mack, et al, The
rationale for Heart Team decision-making for patients with stable,
complex coronary artery disease, Eur. Heart J. 34 (2013) 2510–2518.
https://doi.org/10.1093/eurheartj/eht059.
[27] D.P. Taggart, R. D’Amico, D.G. Altman, Effect
of arterial revascularisation on survival: a systematic review of
studies comparing bilateral and single internal mammary arteries.,
Lancet (London, England). 358 (2001) 870–5.
https://doi.org/10.1016/S0140-6736(01)06069-X.